{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibnj45gzbxfgarddc53mshfdk5jolloao5wlhgd7lsuamkr5vagle",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mjj4b5jlpgn2"
  },
  "path": "/2026/04/15/wuxi-biologics-achieves-iso-13485-certification-signifying-strong-capabilities-in-drug-device-combination-product-development-and-manufacturing/",
  "publishedAt": "2026-04-15T02:39:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Company is among the first in China’s drug-device combination products sector to obtain this certification, delivering superior solutions to global clients Zero non-conformities demonstrates company’s robust quality management system SHANGHAI, April 15, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has successfully achieved ISO […]",
  "title": "WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing"
}